Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.31 USD
+0.01 (1.64%)
Updated Nov 21, 2024 04:00 PM ET
After-Market: $0.30 -0.01 (-3.23%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/3/25 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | 40.00% |
ABR | 2.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.24 |
Next Year | -0.74 |
EPS (TTM) | -1.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.00M | NA | 7.54M | 7.84M |
# of Estimates | 2 | NA | 2 | 2 |
High Estimate | 2.97M | NA | 9.94M | 12.55M |
Low Estimate | 1.02M | NA | 5.14M | 3.12M |
Year ago Sales | 3.00M | 2.14M | 20.97M | 7.54M |
Year over Year Growth Est. | -33.50% | NA | -64.04% | 3.91% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | NA | -1.24 | -0.74 |
# of Estimates | 2 | NA | 2 | 2 |
Most Recent Consensus | -0.10 | NA | -1.12 | -0.34 |
High Estimate | -0.10 | NA | -1.12 | -0.34 |
Low Estimate | -0.25 | NA | -1.35 | -1.13 |
Year ago EPS | -0.59 | -0.56 | -2.19 | -1.24 |
Year over Year Growth Est. | 69.49% | NA | 43.38% | 40.32% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | NA | -1.24 | -0.74 |
7 Days Ago | -0.18 | NA | -1.24 | -0.74 |
30 Days Ago | -0.18 | NA | -1.24 | -0.74 |
60 Days Ago | -0.18 | NA | -1.24 | -0.74 |
90 Days Ago | -0.18 | NA | -1.24 | -0.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | NA | -1.24 | -0.74 |
Zacks Consensus Estimate | -0.18 | NA | -1.24 | -0.74 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.37 | -0.56 | -0.59 | NA |
Estimate | -0.25 | -0.29 | -0.38 | -0.57 | NA |
Difference | 0.10 | -0.08 | -0.18 | -0.02 | -0.05 |
Surprise | 40.00% | -27.59% | -47.37% | -3.51% | -9.62% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more